Bibliography
Wyde, P. R., Chetty, S. N., Timmerman, P., Gilbert, B. E., & Andries, K. (2003). Short duration aerosols of JNJ 2408068 (R170591) administered prophylactically or therapeutically protect cotton rats from experimental respiratory syncytial virus infection. Antiviral Research, 60(3), 221â231.
References
24
Referenced
43
10.1002/jmv.1890300208
/ J. Med. Virol. / An epidemic of respiratory syncytial virus in elderly people: clinical and serological findings by Agius (1990)- Andries, K., Moeremans, M., Gevers, T., Willebrords, R., Lacrampe, J., Janssens, F., 2000. R170591, a novel fusion inhibitor with picomolar activity against respiratory syncytial virus (RSV). In: Proceedings of the 40th Interscience Conference on Antimicrobial Agents and Chemotherapy, Toronto, Canada, 17–20 September, 2000 (Abstracts).
-
Andries, K., Moeremans, M., Gevers, T., Willebords, R., Sommen, C., Lacrampe, J., Janssens, F., Wyde, P.R., in press. Substituted benzimidazoles with nanoMolar activity against respiratory syncytial virus. Antivir. Res.
(
10.1016/j.antiviral.2003.07.004
) 10.1002/ppul.1084
/ Pediatr. Pulmonol. / Respiratory syncytial virus immune globulin: decisions and cost by Barton (2001)-
Committee on Infectious Diseases, 1993. Use of ribavirin in the treatment of respiratory syncytial virus infection. Pediatrics 92, 501–504.
(
10.1542/peds.92.3.501
) 10.1016/S0002-9343(97)00003-X
/ Am. J. Med. / Respiratory viral infections in immunocompetent and immunocompromised persons by Couch (1997)10.1093/infdis/172.2.389
/ J. Infect. Dis. / Respiratory syncytial virus and influenza a infections in the hospitalized elderly by Falsey (1995)10.1016/S0140-6736(05)80082-0
/ Lancet / Respiratory syncytial virus or influenza by Fleming (1993)10.1016/0166-3542(92)90088-M
/ Antivir. Res. / Further studies with short duration ribavirin aerosol for the treatment of influenza virus infection in mice and respiratory synctytial virus infection in cotton rats by Gilbert (1992)- Hall, C.B., McCarthy, C.A., 2000. Respiratory syncytial virus. In: Mandell, G.L., Bennett, J.E., Dolin, R. (Eds.), Mandell, Douglas and Bennett’s Principles and Practice of Infectious Diseases. Churchill Livingston, Philadelphia, pp. 1782–1801.
{'key': '10.1016/j.antiviral.2003.07.002_BIB11', 'first-page': '284', 'article-title': 'Prophylaxis in RSV infection (Palivizumab)—is it worthwhile?', 'volume': '93', 'author': 'Hashmi', 'year': '2000', 'journal-title': 'Ir. Med. J.'}
/ Ir. Med. J. / Prophylaxis in RSV infection (Palivizumab)—is it worthwhile? by Hashmi (2000)10.1016/0165-1218(87)90111-X
/ Mutat. Res. / Dominant lethal study of ribavirin in male rats by Hoffmann (1987)10.1016/S0378-4347(98)00136-4
/ Rev. J. Chromatogr. / Chloroformates in gas chromatography as general purpose derivatizing agents by Husek (1998)10.1007/BF01975037
/ Eur. J. Clin. Microbiol. Infect. Dis. / Antiviral therapy with small particle aerosols by Knight (1988)10.1097/00006454-200205000-00037
/ Pediatr. Infect. Dis. J. / Safety issues related to the administration of ribavirin by Krilov (2002)10.1016/S0149-2918(00)83032-5
/ Clin. Ther. / Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost-effectiveness analysis by Lofland (2000)10.1016/S0022-3476(95)70434-5
/ J. Pediatr. / Cost of ribavirin therapy for respiratory syncytial virus infection by Marquardt (1995)10.1046/j.1440-1754.2000.00303.x
/ J. Paediatr. Child. Health / Outcome of respiratory syncytial virus infection and a cost-benefit analysis of prophylaxis by Numa (2000)-
Rhodes, A.J., Van Rooyen, C.E., 1953. Textbook of Virology, 2nd ed. Williams and Wilkins, Baltimore, MD, pp. 66–69.
(
10.4269/ajtmh.1953.2.5.TM0020050943a
) 10.1542/peds.100.3.417
/ Pediatrics / RSV-IGIV therapy: a cost/benefit analysis by Thakur (1997)10.1001/jama.289.2.179
/ JAMA / Mortality associated with influenza and respiratory syncytial virus in the United States by Thompson (2003)10.1128/AAC.17.4.642
/ Antimicrob. Agents Chemother. / Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice by Wilson (1980)10.1016/0166-3542(87)90029-5
/ Antivir. Res. / Efficacy of high dose-short duration ribavirin aerosol in the treatment of respiratory syncytial virus infected cotton rats and influenza B virus infected mice by Wyde (1987)10.1203/00006450-199510000-00012
/ Pediatr. Res. / Evaluation of the protective efficacy of reshaped human monoclonal antibody RSHZ19 against respiratory syncytial virus in cotton rats by Wyde (1995)
Dates
Type | When |
---|---|
Created | 21 years, 11 months ago (Sept. 16, 2003, 5:11 p.m.) |
Deposited | 8 months, 1 week ago (Dec. 13, 2024, 3:14 p.m.) |
Indexed | 3 months, 2 weeks ago (May 10, 2025, 12:28 a.m.) |
Issued | 21 years, 9 months ago (Nov. 1, 2003) |
Published | 21 years, 9 months ago (Nov. 1, 2003) |
Published Print | 21 years, 9 months ago (Nov. 1, 2003) |
@article{Wyde_2003, title={Short duration aerosols of JNJ 2408068 (R170591) administered prophylactically or therapeutically protect cotton rats from experimental respiratory syncytial virus infection}, volume={60}, ISSN={0166-3542}, url={http://dx.doi.org/10.1016/j.antiviral.2003.07.002}, DOI={10.1016/j.antiviral.2003.07.002}, number={3}, journal={Antiviral Research}, publisher={Elsevier BV}, author={Wyde, Philip R and Chetty, Srikrishna N and Timmerman, Philip and Gilbert, Brian E and Andries, Koen}, year={2003}, month=nov, pages={221–231} }